Nerve growth factor administration protects against experimental diabetic sensory neuropathy
Authors:
- Joseph C. ArezzoJAJoseph C. Arezzo
- Michael BrownleeMBMichael Brownlee
- Howard FederoffHFHoward Federoff
- John A. KesslerJKJohn A. Kessler
- 1 January 1994
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 634 (1) , 7-12
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Nerve growth factor prevents experimental cisplatin neuropathyAnnals of Neurology, 1992
- Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantationNeuroscience Letters, 1991
- Nerve growth factor prevents toxic neuropathy in miceAnnals of Neurology, 1991
- Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathyJournal of Neuroscience Research, 1990
- Hypoxic neuropathy Does hypoxia play a role in diabetic neuropathy?Neurology, 1989
- Nerve growth factor regulates expression of neuropeptide genes in adult sensory neuronsNature, 1989
- The Nerve Growth Factor 35 Years LaterScience, 1987
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987
- Nerve growth factor stimulates development of substance P in the embryonic spinal cordBrain Research, 1981
- Effects of substance P on functionally identified units in cat spinal cordBrain Research, 1976